Related Experiment Videos

Identification, purification, and subcellular localization of prostate-specific membrane antigen PSM' protein in the

L S Grauer1, K D Lawler, J L Marignac

  • 1Hybritech Incorporated, Beckman Coulter, Inc., San Diego, California 92196-9006, USA.

Cancer Research
|November 11, 1998
PubMed

Insights

Researchers purified the prostate-specific membrane antigen (PSMA) splice variant, PSM

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Prostate-specific membrane antigen (PSMA) is a transmembrane protein implicated in prostate cancer.
  • An alternatively spliced variant, PSM', has been identified at the mRNA level in normal prostate tissue.

Purpose of the Study:

  • To purify and characterize the PSM' protein from LNCaP cells.
  • To determine the N-terminus and cellular localization of the PSM' protein.

Main Methods:

  • Immunoaffinity chromatography using two monoclonal antibodies (7E11 and PEQ226.5) in tandem.
  • Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) for protein size determination.
  • N-terminal amino acid sequencing and cell fractionation.

Main Results:

  • PSM' protein was successfully purified from LNCaP cell lysate.
  • Purified PSM' exhibited an apparent molecular weight of 95,000 Da, slightly smaller than full-length PSMA (100,000 Da).
  • N-terminal sequencing confirmed PSM' begins at residue 60 of PSMA, and it was localized to the cytoplasm of LNCaP cells.

Conclusions:

  • The PSM' protein is a distinct, shorter variant of PSMA, differing in its N-terminus.
  • PSM' is present in the cytoplasm of LNCaP cells, suggesting potential distinct functions from cell surface PSMA.

Related Concept Videos